A study to assess utilisation and safety of Glycopyrronium Bromide 1mg/5ml Oral Solution as licensed for symptomatic treatment of severe sialorrhoea in children and adolescents aged 3 years and older with chronic neurological disorders in the UKFirst published 20/02/2023 Last updated 23/04/2024 EU PAS number: EUPAS103644StudyOngoing
Drug Safety Research Unit (DSRU)United Kingdom First published: 10/11/2021Last updated 16/02/2024 InstitutionNot-for-profitENCePP partner
NIHR Medicines for Children Research Network First published: 01/02/2024Last updated 01/02/2024 Network